Normal view MARC view ISBD view

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

In CA: A Cancer Journal for Clinicians
By: Saslow D.
Contributor(s): Russell CA | Andrews KS | Yaffe M | Warner E | Smith R | Sener S | Schnall M | Pisano E | Morris E | Lehman CD | Leach MO | Harms S | Burke W | Boetes C | .
Material type: materialTypeLabelArticleSeries: Vol 57 Issues 2.Publisher: 2007Description: 75-89.Subject(s): Mammography | MRI | Breast Screening | American Cancer Society Guidelines | DDC classification: In: CA: A Cancer Journal for CliniciansSummary: New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 2025% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.
Tags from this library: No tags from this library for this title. Add tag(s)
Log in to add tags.
    average rating: 0.0 (0 votes)

New evidence on breast Magnetic Resonance Imaging (MRI) screening has become available since the American Cancer Society (ACS) last issued guidelines for the early detection of breast cancer in 2003. A guideline panel has reviewed this evidence and developed new recommendations for women at different defined levels of risk. Screening MRI is recommended for women with an approximately 2025% or greater lifetime risk of breast cancer, including women with a strong family history of breast or ovarian cancer and women who were treated for Hodgkin disease. There are several risk subgroups for which the available data are insufficient to recommend for or against screening, including women with a personal history of breast cancer, carcinoma in situ, atypical hyperplasia, and extremely dense breasts on mammography. Diagnostic uses of MRI were not considered to be within the scope of this review.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha